<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED FINANCIAL STATEMENTS OF MEDPLUS, INC. AND SUBSIDIARIES AS OF AND FOR THE SIX MONTH PERIOD ENDED JULY 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> JAN-31-2001 <PERIOD-END> JUL-31-2000 <CASH> 6,446,900 <SECURITIES> 0 <RECEIVABLES> 2,653,000 <ALLOWANCES> 155,000 <INVENTORY> 126,600 <CURRENT-ASSETS> 10,318,000 <PP&E> 2,773,118 <DEPRECIATION> 1,631,2000 <TOTAL-ASSETS> 15,001,000 <CURRENT-LIABILITIES> 3,942,500 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 23,700 <COMMON> 0 <OTHER-SE> 11,034,800 <TOTAL-LIABILITY-AND-EQUITY> 15,001,000 <SALES> 2,884,800 <TOTAL-REVENUES> 5,594,000 <CGS> 3,580,800 <TOTAL-COSTS> 4,890,300 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 213,600 <INCOME-PRETAX> (3,077,100) <INCOME-TAX> 0 <INCOME-CONTINUING> (3,077,100) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (3,077,100) <EPS-BASIC> (0.50) <EPS-DILUTED> (0.50)